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a b s t r a c t
Osteogenic differentiation is a multistep process regulated by a diverse set of morphogenic and
transcription factors. Previously we identiﬁed endogenous hydrogen peroxide-induced poly(ADP-ribose)
polymerase-1 (PARP1) activation as a mediator of osteodifferentiation and associated cell death. Here we
set out to investigate whether or not activation of PARP1 is dependent on DNA breaks and how PARP1
mediates cell death during osteodifferentiation of mesenchymal stem cells and SAOS-2 cells. Here we
show that the MAP kinases p38, JNK, and ERK1/2 become activated during the differentiation process.
However, only p38 activation depended both on hydrogen peroxide production and on PARP1 activation
as the hydrogen peroxide decomposing enzyme catalase, the PARP inhibitor PJ34, and the silencing of
PARP1 suppressed p38 activation. Inhibition of p38 suppressed cell death and inhibited osteogenic
differentiation (calcium deposition, alkaline phosphatase activity, and marker gene expression) provid-
ing further support for the close coupling of osteodifferentiation and cell death. Metabolic collapse
appears to be central in the hydrogen peroxide–PARP1–p38 pathway as silencing PARP1 or inhibition of
p38 prevented differentiation-associated loss of cellular NAD, inhibition of mitochondrial respiration,
and glycolytic activity. We also provide evidence that endogenous hydrogen peroxide produced by the
differentiating cells is sufﬁcient to cause detectable DNA breakage. Moreover, p38 translocates from the
cytoplasm to the nucleus where it interacts and colocalizes with PARP1 as detected by immunopreci-
pitation and immunoﬂuorescence, respectively. In summary, hydrogen peroxide-induced PARP1 activa-
tion leads to p38 activation and this pathway is required both for the successful completion of the
differentiation process and for the associated cell death.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Membranous ossiﬁcation involves the differentiation of
mesenchymal stem cells into osteoprogenitors and eventually
osteoblasts. Differentiated osteoblasts produce extracellular
matrix with Type I collagen considered as the prototypical
component of the osteoid matrix [1]. In turn, mineralization
(deposition of calcium, magnesium, and phosphate containing
hydroxyapatite) completes the process resulting in a bone tissue
that is hard and strong enough to fulﬁll skeletal function [2]. This
complex series of events is regulated by a diverse set of transcrip-
tion factors such as osterix, Runx2, Groucho/TLE, or Twist and
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Osteogenic differentiation is accompanied by massive cell
death with the majority of differentiating cells undergoing apop-
tosis [6,7]. The identity and regulation of the cell death subroutine
mediating osteogenic differentiation-coupled cell death, however,
have not yet been completely characterized. Production of reactive
oxygen species has been shown to accompany osteogenesis [8,9]
and our group has established the contribution of the hydrogen
peroxide-induced poly(ADP-ribose) polymerase-1 (PARP1) path-
way to osteogenic differentiation and related cell death [7]. Poly
(ADP-ribosyl)ation is a protein modiﬁcation catalyzed by some
members of the PARP enzyme family. PARP1 is a DNA nick sensor
enzyme catalyzing cleavage of NAD to nicotinamide and ADP-
ribose and covalently attaching the latter to suitable acceptor
proteins. In turn, the ﬁrst protein-bound ADP-ribose unit can serve
as new site for the addition of further ADP-ribose moieties
resulting in the formation of poly(ADP-ribose) (PAR) [10,11]. The
wide range of biological activities of PARP enzymes ranging from
regulation of genome organization, transcription, telomere length,
and metabolism to facilitation of DNA repair and propagation of
cell death are due to (a) covalent PARylation of target proteins,
(b) noncovalent binding of free or protein-bound PAR polymers to
proteins, (c) depletion of cellular NAD and ATP pools, (d) physical
interaction of PARPs with other proteins [12–16]. The role of
PARP1 in cell death regulation is complex and largely depends
on the cellular model and the activating stimulus. Mechanisms
underlying PARP1-mediated necroptotic cell death include cellular
metabolic insufﬁciency (due to NAD and ATP depletion), PAR-
induced nuclear translocation of AIF (apoptosis inducing factor),
and interference with prosurvival and prodeath signaling path-
ways [11,17–19]. As for the latter, signaling routes mediated by
MAP kinases have been shown to be intertwined with PARylation
[20–23]. Of note, it has been shown that the expression of MAP
kinase phosphatase 1 (MKP-1) is negatively regulated by PARP1
strengthening prodeath pathways mediated by JNK and p38 MAP
kinases [24]. Which of these three major PARP1-dependent
mechanisms are responsible for the cell death of differentiating
osteoprogenitors and whether they are connected to the hydrogen
peroxide-mediated redox regulatory pathway that we have pre-
viously identiﬁed remain to be determined.
Since we have previously demonstrated the lack of AIF trans-
location during osteogenic differentiation-coupled cell death [7],
here we set out to investigate the role of MAP kinase signaling and
compromised cellular energetics as possible mediators of PARP1-
dependent cell death during osteogenic differentiation. We show
that while all three MAP kinases become activated during the
course of osteogenic differentiation, inhibition or silencing of
PARP1 only suppresses the activation of p38, while Erk1/2 activa-
tion was augmented and JNK activation was not affected. More-
over, p38 is a downstream mediator of the hydrogen peroxide–
PARP1 cytotoxic pathway mediating not only cell death but the
osteogenic differentiation process as well.
Materials and methods
Bis-benzimide trihydrochloride (Hoechst H33342), 1,4-diazabicy-
clo[2.2.2]octane (DABCO), Mowiol 4–88, protease inhibitor cocktail
(PIC), dexamethasone, β-glycerophosphate disodium salt hydrate,
2-phospho-L-ascorbic acid trisodium salt, vitamin D3 solution, cata-
lase from bovine liver, nitrocellulose membrane, 3,30-diaminobenzi-
dine (DAB), SB239063 and SB203580 (p38 inhibitors), SP600125 (JNK
inhibitor), glycylglycine, niacinamide, alkohol dehydrogenase from
Saccharomyces cerevisiae, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT), phenazine methosulfate, nicotinamide
adenine dinucleotide (NAD), PJ34, lentiviral silencing vectors, anti-
mycin A, oligomycin, and carbonyl cyanide 4-(triﬂuoromethoxy)
phenylhydrazone (FCCP) were purchased from Sigma Aldrich (Buda-
pest, Hungary). Dulbecco’s modiﬁed Eagle medium with sodium
pyruvate and low glucose (DMEM), penicillin-streptomycin solution,
and fetal bovine serum were from Life Technologies (Budapest,
Hungary). The SuperSignal West Pico Chemiluminescent Substrate,
Pierce BCA Protein Assay kit was purchased from Thermo Scientiﬁc
(Waltham, MA). U0126 (MEK1/2 inhibitor), MAPK, and phospho-
MAPK Family Antibody Sampler Kits were from Cell Signaling
Technology (Budapest, Hungary). The FITC Annexin V Apoptosis
Detection Kit I was purchased from BD Biosciences (Pécs, Hungary).
XF96 FluxPak and XF Assay Mediumwere from Seahorse Biosciences
(North Billerica, MA, USA).
Isolation and phenotyping of mesenchymal stem cells
Chorion-derived mesenchymal stem cells (MSC) were isolated
from human placentas (as approved by the regional research
ethics committee under license number DEOEC-RKEB-2946-
2009) and phenotyped on the basis of surface antigen pattern
using cell staining with appropriate antibodies combined with
ﬂow cytometric analysis (Becton Dickinson BD FACSCalibur and BD
Multiset Software v3.0x for Mac OS X) as described previously [7].
Only cells positive for CD73, CD90, CD105, and CD166 and negative
for CD34, CD45, vWF, and HLA-G were used in the experiments.
Cell culture and differentiation
SAOS-2 human osteosarcoma cells and chorion-derived
mesenchymal stem cells were cultured and differentiated as
previously desribed [7].
Generation of SAOS-2 cell line with stably silenced PARP1
PARP1 silenced (shPARP1) SAOS-2 cells were obtained by
transduction with lentiviral vectors containing the insert [con-
structs TRCN0000007929] as described previously [25], while cells
transduced with pLKO.1-puro empty vector served as a negative
control (CTRL). Transduced cells were cultured and differentiated
in the presence of puromycin (5 mg/ml). Stability of silencing was
checked regularly by detection of PARP1 mRNA and protein levels
(qPCR and Western blot, respectively).
Comet assay
In order to study ROS-induced DNA damage, cells were col-
lected on different days of differentiation and were subjected to
the comet assay procedure as previously described [26]. Images
were acquired with a Zeiss Axiolab microscope (Carl Zeiss,
Oberkochen, Germany) with a Zeiss Axiocam digital camera. The
degree of DNA damage was estimated on the basis of tail DNA (%)
calculated with CASPLab Comet Assay Software. Red to black ratio
of acquired images was enhanced by adjustment of brightness,
contrast, hue, and saturation. Subsequent conversion of color
images to grayscale was followed by inversion. These adjustments
were carried out on all images in an identical manner.
Immunoprecipitation
Immunoprecipitation of PARP1, p38, or phosphorylated p38
(P-p38) was carried out according to Rothgiesser et al. [27]. Cell
lysates were incubated with either anti-PARP1 rabbit polyclonal
antibody [generated against a peptide fragment (amino acids 506–
523) of human PARP1] or anti-p38 or anti-phospho-p38 antibo-
dies. Protein–antibody complexes were pulled down with Dyna-
beads Protein G and subjected to Western blot analysis [7]. Images





































































































































A. Robaszkiewicz et al. / Free Radical Biology and Medicine ∎ (∎∎∎∎) ∎∎∎–∎∎∎2
Please cite this article as: Robaszkiewicz, A; et al. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in
the osteogenic differentiation-coupled cell.... Free Radic. Biol. Med. (2014), http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.027i
Western blot
In order to determine the involvement of MAP kinases in
osteogenic differentiation, analysis of MAP kinase phosphorylation
was carried out with Western blot as previously described [7].
Cell viability
The percentage of viable and nonviable cells was quantiﬁed
using an Annexin V-FITC/propidium iodide kit (Becton-Dickinson)
as described previously [7]. Cells were analyzed with a Becton–
Dickinson BD FACS Calibur ﬂow cytometer and the acquired data
were processed with BD Multiset software version 3.0x for Mac OS
X (Becton–Dickinson). Cells were classiﬁed as “viable” (weak green
and weak red ﬂuorescence), “apoptotic” (strong green and weak or
strong red ﬂuorescence), and “necrotic” (weak green and strong
red ﬂuorescence).
Characterization of osteogenic differentiation
Osteogenic differentiation was characterized by measuring calcium
deposition (Alizarin red staining), quantifying alkaline phosphatase
activity (enzyme activity assay), and the expression of osteogenic
marker genes (osterix, RUNX2 and BMP-2) by qPCR. All these assays
were carried out exactly as described in Robaszkiewicz et al. [7]. The
list of primers used is given in Supplementary Material 1.
RNA extraction, reverse transcription, and real-time PCR analysis
Total RNA was isolated from cells with TRI reagent as described
previously [7]. Isolated RNA was reverse-transcribed to cDNA with
the High Capacity cDNA reverse transcription kit purchased from
Fermentas, Thermo Scientiﬁc (Waltham, MA). For real-time PCR
Maxima SYBR Green qPCR Master Mix (Fermentas, Thermo Scien-
tiﬁc, Waltham, MA) was used. Genes were ampliﬁed with an
Applied Biosystems 7500 Fast Real-Time PCR system. The expres-
sion levels of genes analyzed were normalized to glyceraldehyde-
3-phosphate dehydrogenase as reference housekeeping gene.
NAD assay
The intracellular concentration of NAD was measured in
differentiating cells with the recycling assay according to pre-
viously published protocol [25]. Data were normalized to protein
determined with a Pierce BCA protein assay kit (according to
instructions provided by the manufacturer).
Metabolic activity
Bioenergetic analysis was carried out using the Seahorse XF96
Analyzer (Seahorse Biosciences, MA, USA) as described in Modis
et al. [28], which allows the simultaneous and real-time analysis of
the oxygen consumption rate (OCR) and extracellular acidiﬁcation
rate (ECAR), which correspond to mitochondrial and glycolytic
activity of cells, respectively. Prior to the analysis, differentiating
medium was changed to unbuffered DMEM medium supplemen-
ted with 1% glucose. Sequential injection of oligomycin (20 mg/ml),
FCCP (9 mM), and antimycin (20 mg/ml) through Seahorse FluxPak
cartridges permitted the determination of the following metabolic
parameters: ECARNM, nonmitochondrial proton release, which
represents glycolytic activity; OCRBR, basal respiration, which
corresponds to ATP-linked mitochondrial oxygen consumption,
maximum respiratory rate, and respiratory reserve capacity
(OCRMRR and OCRRRC, respectively) as well as nonmitochondrial
oxygen consumption.
Immunocytochemistry and immunoﬂuorescence
8-Hydroxydeoxyguanosine (8OHdG), a marker of oxidative
DNA damage, was detected by immunocytochemistry. Preparation
of samples and denaturation of cellular DNA was performed as
described in Yamamoto et al. [29]. After 30 min incubation with
8OHdG antibody (Jaica, Shizuoka, Japan; clone N45.1; 1:30 dilution
in 5% FBS, at 37 1C) a standard immunocytochemistry protocol was
followed as previously described [25]. Samples were mounted in
Mowiol and viewed with a Zeiss Axiovision microscope.
Colocalization of p38 and PARP1 was determined by immuno-
ﬂuorescent double staining using mouse anti-PARP1 (Sigma-
Aldrich, Budapest, Hungary) and rabbit polyclonal anti-p38 anti-
bodies (Cell Signaling Technology, Danvers, MA, USA) followed by
incubation with AlexaFluor633-conjugated anti-mouse and
AlexaFluor488-conjugated anti-rabbit IgG antibody (Life Technol-
ogies, Budapest, Hungary). Samples were viewed and imaged with
a Leica SP8 confocal microscope.
NADPH oxidase activity
Activity of NADPH oxidase was measured according to Wang
et al. [30]. The ratio of lucigenin oxidation was normalized to
protein content (quantiﬁed with a Pierce BCA protein assay kit).
Mitochondrial superoxide production
Mitochondrial superoxide production was monitored on the
basis of MitoSOX oxidation as described in Robaszkiewicz et al.
[31]. Cells were analyzed with a Becton–Dickinson BD FACS Calibur
ﬂow cytometer and the acquired data were processed with BD
Multiset software version 3.0x for Mac OS X (Becton–Dickinson).
Results
Osteogenic differentiation is accompanied by DNA breakage
Since PARP activation may be induced by DNA breaks and may
also occur in the absence of DNA damage [16], ﬁrst we set out to
look for signs of DNA breaks in differentiating cultures. Differ-
entiation of both MSC and SAOS-2 cells was accompanied by DNA
strand breaks as detected with the comet assay (Fig. 1a). Of note,
the appearance of DNA damage corresponded to the pattern of
hydrogen peroxide release and PAR synthesis as documented
previously [7]. Moreover, addition of the hydrogen peroxide
decomposing enzyme catalase to the osteogenic differentiation
medium prevented the formation of DNA strand breaks (Fig. 1a),
indicating that hydrogen peroxide produced in the course of
osteogenic differentiation is responsible for DNA breakage. The
oxidative nature of DNA damage is further supported by the
presence of 8OHdG in the differentiating cells, as detected by
immunocytochemistry (Fig. 1b).
Activation proﬁling of MAP kinases during osteogenic differentiation
of SAOS-2 and mesenchymal stem cells
Enzymes belonging to the family of mitogen-activated protein
kinases (MAPK) p38, JNK, and ERK1/2 play diverse roles in various
models of cell death [32–35]. Osteogenic differentiation in SAOS-2
and MSC cells was also accompanied by marked changes in the
phosphorylation state of three major MAP kinases (Fig. 2, Fig. S1,
and Fig. S2). By day 6 of differentiation the phosphorylation level
of p38 kinase increased approximately 7 fold in both cell types as
compared to day 0 (Fig. 2). Similarly, phosphorylation of both ERK
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course of differentiation with some notable differences between
SAOS-2 and MSC cells. Whereas in MSC an early activation of JNK
and ERK1/2 (on days 1 and 2, respectively) could be observed, in
SAOS-2 cells basal JNK phosphorylation was slightly downregu-
lated in the ﬁrst 2 days followed by a late (days 4 and 5)
upregulation. Activation of ERK1/2 began to increase slowly
on day 4.
The hydrogen peroxide–PARP1 pathway is intertwined with MAP
kinase activation
In order to conﬁrm that the previously described hydrogen
peroxide–PARP1 pathway is connected to the activation of one or
more MAP kinases we have investigated the effects of catalase that
decomposes hydrogen peroxide and the pharmacological PARP
inhibitor PJ34. We found that catalase (1 kU/ml) prevented the
phosphorylation of p38 kinase in both MSC and SAOS-2 cells
(Fig. 2) but had no major effect on the ERK (Fig. S1) and JNK
pathways (Fig. S2). The PARP1 inhibitor PJ34 (1 mM) also sup-
pressed p38 activation (Fig. 2) but augmented ERK phosphoryla-
tion (Fig. S1) without affecting JNK activation (Fig. S2). In order to
prove that the primary target of the PARP inhibitor PJ34 is PARP1
in this model, we silenced the parp1 gene in SAOS-2 cells and
performed MAP kinase proﬁling in these cells (shPARP1 cells).
Data obtained with shPARP1 cells phenocopied results obtained
with the PARP inhibitor (Fig. 2, S1, and S2) indicating that PARP1
indeed inversely regulates p38 and ERK kinases during osteogenic
differentiation. (Similar to the PARP inhibitor PJ34, PARP1 silencing
had no effect on the activation of JNK.) As literature data suggested
a possible cross-inactivation between p38 and ERK [36], we have
investigated whether augmentation of ERK activation by PARP
inhibition is due to suppression of p38. We could not conﬁrm this
hypothesis in our model of osteogenic differentiation as inhibition
of p38 by the pharmacological inhibitor SB239063 (5 mM) had no
effect on the course of ERK activation either in SAOS-2 or in MSC
cells (data not shown).
p38 mediates osteogenic differentiation-coupled cell death
Previously we have shown that hydrogen peroxide-induced
PARP activation is required for osteogenic differentiation via
mediating differentiation-coupled cell death [7]. Here we set out
to investigate whether any of the MAP kinases are involved in this
regulatory pathway. We found that inhibition of p38 but not that
of ERK (MEK) or JNK protected cells from apoptotic death accom-
panying osteogenic differentiation (Fig. 3). In fact, pretreatment of
cells with ERK or JNK inhibitors slightly sensitized cells to rather





































































































































Fig. 1. ROS generated during osteogenic differentiation is responsible for differentiation-associated DNA damage. Differentiating cells (DIFF) and differentiating cells
supplemented with 1 kU/ml catalase (DIFFþCAT) were collected at selected days. DNA damage was detected with comet assay (a), whereas oxidative DNA damage was
veriﬁed by immunocytochemical detection of 8-hydroxy-20-deoxyguanosine (8-OHdG) (b). (a) Representative images of SAOS-2 and MSC cells acquired on day 4 are
presented. The degree of DNA damage was quantiﬁed by calculating tail DNA (%) and presented on the bar graphs. Each value represents mean7SEM (nZ3). For statistical
analysis Student’s t-test was employed: Asterisks indicate signiﬁcant differences with respect to day 0: *(Po0.05), **(Po0.01), ***(Po0.001); hashmarks indicate signiﬁcant
difference with respect to the corresponding day of the osteo-differentiating cells (DIFF): #(Po0.05), ##(Po0.01), ###(Po0.001). (b) Representative images of SAOS-2 cells
stained for 8OHdG and acquired on days 0, 3, and 6 are presented. UV irradiated SAOS-2 cells were used as positive control.
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a downstream player in the hydrogen peroxide–PARP1 pathway
contributing to cell death in differentiating MSC and SAOS-2 cells.
Based on our previous observation that osteogenic differentiation
and cell death appear to be closely coupled with each other we
assumed that p38 should also inhibit the differentiation process.
Indeed, the p38 inhibitor SB239063 suppressed markers of osteo-
genic differentiation such as calcium deposition (Fig. 4a, c, d, and f)
and ALP activity (Fig. 4b and e) both in MSC and in SAOS-2
cultures. Moreover, experiments repeated with another p38 inhi-
bitor (SB203580) conﬁrmed the pivotal role of p38 in osteodiffer-
entiation and cell death (data not shown). p38 inhibition had no
effect on nondifferentiating cells that showed no sign of increased
cell death.
Since these data clearly identiﬁed p38 as a downstream
mediator of the H2O2–PARP1 differentiation and cell death path-
way, in the following part of the study we focused on the
characterization of the role of this MAP kinase in osteodifferentia-
tion and coupled cell death.
The PARP1–p38 cytotoxic pathway culminates in cellular energetic
failure during osteogenic differentiation-coupled cell death
Hydrogen peroxide-induced protein poly(ADP-ribosyl)ation
prompted us to analyze cellular levels of NAD, the substrate of
PARP1 which is also utilized as a cofactor in metabolic pathways,
thereby linking PARP1 activity to metabolic failure, possibly
contributing to cell death [11].
Osteogenic differentiation of SAOS-2 and MSC cells was accom-
panied by a progressive decrease in the concentration of intracellular
NAD (Fig. 5a and g). Supplementation of osteogenic mediumwith the
PARP inhibitor PJ-34 (1 mM) signiﬁcantly protected cells against the
loss of NAD (Fig. 5a and g) similar to PARP1 silencing (Fig. 5d).
Moreover, nondifferentiating (day 0) shPARP1 cells demonstrated
slightly but signiﬁcantly higher values of total cellular NAD when
compared to control cells (CTRL).
The loss of NAD was followed by the decrease in metabolic
activity of differentiating cells. Intensity of glycolysis, mirrored by
ECARNM as well as ATP synthesis-associated mitochondrial respira-
tion, mirrored by OCRBR, declined as a consequence of osteogenic
differentiation (Fig. 5). Simultaneous collapse of two major intracel-
lular sources of ATP suggests metabolic failure possibly resulting
from the NAD utilization by PARP1. In order to verify this hypothesis
we differentiated both cell lines in the presence of PJ34 (1 mM) and
employed PARP1-silenced SAOS-2 cells (shPARP1 cells). Similar to
PARP1 inhibition, PARP1 silencing also prevented deterioration of
mitochondrial respiration and glycolysis, indicating the negative
effects of this enzyme on cellular metabolism (Fig. 5).
To further characterize mitochondrial failure we tested the effects
of mitochondrial uncoupling compounds (oligomycin, FCCP, and
antimycin) in an extracellular ﬂux assay in SAOS-2 and shPARP1
cells (Fig. S3) in order to determine respiratory reserve capacity
(OCRRRC) and maximum respiration rate (OCRMRR). These two para-
meters provided further proof for restricted mitochondrial activity of
differentiated cells and also conﬁrmed protection by PARP1 silencing.
Based on the functional interplay between PARP1 and p38 and
the role of PARP1 in differentiation-associated metabolic dysfunc-
tion, we set out to investigate the role of p38 in the metabolic





































































































































Fig. 2. H2O2-induced poly(ADP-ribosyl)ation mediates activation of p38 MAP kinase in differentiating MSC and SAOS2 cells. Phosphorylation of p38 MAP kinase during
osteogenic differentiation of MSC cells (a) or SAOS2 cells (b) was determined by Western blotting without pretreatment or in the presence of catalase (1 kU/ml) or PJ34 (as
indicated on the ﬁgure). SAOS2 cells with silenced PARP1 (shPARP1) have also been induced to undergo differentiation (c). Intensity of bands was quantiﬁed by measuring
the relative optical density (OD) of the bands and data are presented as fold change of phoshorylated kinase to total kinase (d). Each value represents mean7SEM (nZ3). For
statistical analysis Student’s t test was employed: Asterisks indicate signiﬁcant differences with respect to day 0: *(Po0.05), **(Po0.01), ***(Po0.001); hashmarks indicate
signiﬁcant differences with respect to the corresponding day of the osteodifferention (DIFF): #(Po0.05), ##(Po0.01), ###(Po0.001).
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of osteogenic medium with the p38 inhibitor SB239063 for the
whole differentiation process completely prevented the drop in
the concentration of intracellular NAD in both studied cell types
(Fig. 6a and d). Preservation of the cellular NAD pool was
accompanied by preserved metabolic activity of differentiating
cells (Fig. 6b, c, e, and f). However, protection of ATP synthesis-
associated mitochondrial respiration (OCRBR) by the p38 inhibitor
was more prevalent than that of glycolysis (ECARNM) (Fig. 6b, c, e,
and f).
PARP1 and p38 interact and colocalize with each other in
differentiating cells
Next we set out to investigate whether PARP1 and p38 interact
with each other. We found that protein–protein interaction
between the two proteins indeed develops during the differentia-
tion process as evidenced by immunoprecipitation experiments
(Fig. 7). Coimmunoprecipitation of p38 and PARP1 could be
observed in two-way experiments: immunoprecipitation of PARP1
followed by Western blot detection of p38 (Fig. 7a) or immuno-
precipitation of p38 or phospho-p38 followed by Western blot
detection of PARP1 (Fig. 7b). Nonbinding (NB) controls (super-
natants obtained after ﬁrst centrifugation of beads) displayed
virtually no positive bands (Fig. 7b). Parallel experiments per-
formed without primary antibody also failed to immunoprecipi-
tate any protein, indicating that binding is not due to nonspeciﬁc
interaction between beads and our proteins of interest (data not
shown). Immunoﬂuorescent double staining for the two proteins
revealed that in resting (nondifferentiating) cells p38 and PARP1
localize to the cytoplasm and to the nucleus, respectively. In
differentiating cells, however, nuclear translocation of p38 can
be observed and the two proteins colocalize in the nucleus
(Fig. 7c).
Discussion
Regulation of osteogenic differentiation and cell death asso-
ciated with the differentiation process is under the control of
complex regulatory circuits. Recently we identiﬁed a redox reg-
ulatory pathway contributing to the control of osteodifferentiation





































































































































Fig. 3. Effect of MAP kinase inhibitors on cell death during osteogenic differentiation of SAOS-2 and mesenchymal stem cells. SAOS-2 and MSC cells differentiated in the
absence and presence of MAP kinase inhibitors were double stained with Annexin V and propidium iodide and cell death was analyzed by ﬂow cytometry. The number of
viable (Annexin V and propidium iodide double negative), apoptotic (Annexin V single positive or Annexin V and propidium iodide double positive), and necrotic (propidium
iodide single positive) cells was quantiﬁed as described under Materials and methods. Each value represents mean7SEM (nZ3). For statistical analysis Student’s t test was
employed: Asterisks indicate signiﬁcant differences with respect to day 0: *(Po0.05), **(Po0.01), ***(Po0.001); hashmarks indicate signiﬁcant differences with respect to
the corresponding day of the osteo-differentiating cells (DIFF): #(Po0.05), ##(Po0.01), ###(Po0.001).
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the activation of PARP1 in response to production of reactive
oxygen species in differentiating cells. Analysis of mitochondrial
superoxide production and NADPH oxidase (NOX) activity showed
that superoxide may be released by both sources. However,
MitoSOX oxidation occurred relatively late and thus might not be





































































































































Fig. 4. p38 kinase mediates osteogenic differentiation of mesenchymal stem cells and SAOS-2 cells. The effect of the p38 inhibitor SB239063 (5 mM) on osteogenic
differentiation markers was studied during the course of osteogenic differentiation in both types of cells. Alkaline phosphatase activity (b and e) was determined in
colorimetric assays (as described under Materials and methods). For evaluation of matrix mineralization cells were stained with Alizarin Red S (stains calcium). Alizarin Red
S-stained cultures were photographed with a microscope equipped with a digital camera (c and f) or Alizarin Red S was solubilized and absorbance was read at 540 nm (a
and d). Each value represents mean7SEM (nZ3). For statistical analysis Student’s t test was employed: Asterisks indicate signiﬁcant differences with respect to day 0:
*(Po0.05), **(Po0.01), ***(Po0.001); hashmarks indicate signiﬁcant differences with respect to the corresponding day of the osteodifferentiating cells (DIFF): #(Po0.05),
##(Po0.01), ###(Po0.001).
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NOX activity (and expression of two NOX isoforms) closely
resembled that of H2O2 production, suggesting that NOX may be
the most likely source of H2O2 causing DNA damage and PARP
activation in our model (Fig. S4). This is also in agreement with
previous ﬁndings on the contribution of NOX to BMP2-stimulated
osteoblast differentiation [8,37]. However, several open questions
such as the nature of connection between ROS production and the
activation of PARP1 as well as mediators of downstream signaling
remain to be elucidated.
In cells exposed to relatively high concentrations of exogenous
reactive oxygen species such as exogenous hydrogen peroxide or
peroxynitrite, the trigger for PARP activation is ROS-induced DNA
breakage [38]. However, several alternative mechanisms leading to the
activation of PARP1 in the absence of DNA damage have also been
described [39–42]. Here we have shown that a low concentration of
hydrogen peroxide produced “physiologically” by cells induced to
undergo osteodifferentiation is sufﬁcient to induce DNA breakage as
evidenced by the comet assay. DNA breaks are caused by endogenous
hydrogen peroxide production as decomposition of hydrogen peroxide
by catalase treatment prevented the formation of DNA breaks. The
oxidative nature of DNA damage in this model was also indicated by
the appearance of 8OHdG in the differentiating cells. The ﬁnding of
oxidative DNA damage in a differentiation model was slightly surpris-
ing to us in light of the generally held view that cells are abundantly
equipped with a plethora of antioxidants (both enzymatic and none-
nzymatic) to prevent signiﬁcant macromolecular damage. It appears
possible that extended production of low amounts of hydrogen
peroxide can break through the barrier formed by antioxidant defense
mechanisms and cause cellular damage. Similar observations have
previously been made by Rodríguez-Vargas et al. [43] demonstrating
ROS production, DNA damage, and PARP1 activation in cells under-
going starvation-induced autophagy, suggesting that this pathway
may not be restricted to osteogenic differentiation but may be
operational in various diverse cellular systems. In the autophagy
model, PARP1 activation has been shown to positively feed back to





































































































































Fig. 5. PARP1 mediates metabolic collapse during osteodifferentiation-coupled cell death. SAOS-2 (a–c), PARP1-silenced SAOS-2 (d–f), and mesenchymal stem cells (MSC)
(g–i) were induced to undergo osteodifferentiation in the presence or absence of PJ34 (1 mM). Intracellular NAD (a, d, g), extracellular acidiﬁcation rate (ECARNM)
corresponding to glycolytic activity (b, e, h), oxygen consumption rate (OCRBR) representing mitochondrial respiration (c, f, i) were determined by performing extracellular
ﬂux measurements with a Seahorse XF96 analyzer. Each bar represents mean7SEM (nZ3). For statistical analysis Student’s t test was employed: asterisks indicate
signiﬁcant differences with respect to day 0: *(Po0.05), **(Po0.01), ***(Po0.001); hashmarks indicate signiﬁcant differences with respect to the corresponding day of the
osteo-differentiating cells (DIFF): #(Po0.05), ##(Po0.01), ###(Po0.001).
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in osteodifferentiation, but conﬁrming this hypothesis requires further
investigation.
The central question in our current study was to identify mechan-
isms downstream of PARP1 which can mediate osteodifferentiation-
coupled cell death. Activation of PARP1 can lead to cell death via
different pathways: parthanatos, NAD/ATP depletion, and activation of
death signaling routes such as the ones mediated by MAP kinases. The
parthanatos pathway involves the release of the PAR polymer from the
nucleus, its translocation to the mitochondria, and stimulation of the





































































































































Fig. 6. p38 kinase contributes to metabolic collapse accompanying osteogenic differentiation. SAOS-2 (a–c) and mesenchymal stem cells (MSC) (d–f) were induced to
undergo osteodifferentiation in the presence or absence of inhibitors of p38 or MEK. Intracellular NAD (a, d), extracellular acidiﬁcation rate (ECARNM) corresponding to
glycolytic activity (b, e), oxygen consumption rate (OCRBR) representing mitochondrial respiration (c, f) were determined with a Seahorse XF96 analyzer. Each bar represents
mean7SEM (nZ3). For statistical analysis Student’s t test was employed: Asterisks indicate signiﬁcant differences with respect to day 0: *(Po0.05), **(Po0.01),
***(Po0.001); hashmarks indicate signiﬁcant differences with respect to the corresponding day of the osteodifferentiating cells (DIFF): #(Po0.05), ##(Po0.01),
###(Po0.001).
Fig. 7. Protein–protein interaction between and colocalization of PARP1 and p38 during osteogenic differentiation of SAOS-2 cells. Physical interaction between PARP1 and
p38 was detected in immunoprecipitation experiments (a and b). Immunoprecipitation was carried out with anti-PARP1 (a), anti-p38 (b), or phospho-p38 (b) antibodies
followed by Western blots for PARP1 and p38 (E, eluate; NB, nonbinding control). Colocalization of PARP1 and p38 as conﬁrmed by double immunoﬂuorescent staining is
presented in panel (c). In contrast to undifferentiated samples (day 0), staining patterns observed on day 3 of differentiation show a clear colocalization of PARP1 and p38.
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it triggers caspase-independent DNA fragmentation and necroptotic
cell death. Previously we have demonstrated the lack of mito-
chondrio-nuclear translocation of AIF during osteodifferentia-
tion-induced cell death [7]. Suppression of cellular metabolism (due
to depletion of cellular NAD and consequently that of ATP) has also
been made responsible for PARP-mediated cellular suicide. Here we
found that osteogenic differentiation-coupled cell death is accompa-
nied by depletion of NAD, the substrate of PARP, suppression of both
glycolysis and basal as well as maximal mitochondrial respiration.
Collapse of cellular energetics was due to ROS production as catalase
prevented metabolic dysfunction of differentiating cells (data not
shown). Moreover, activation of PARP1 is also a key mediator of
differentiation-associated metabolic derailment as pretreatment of
cells with the pharmacological PARP inhibitor PJ-34 or silencing PARP1
rescued cells from energy crisis. It seems, however, that the relation-
ship between PARP activation and energetic collapse is more complex
than simply being caused by NAD depletion as p38 MAP kinase was
identiﬁed by this study as mediator of the energetic effects of
PARylation (Fig. 6). MAP kinases have previously been linked to
PARylation by several observations. However, the nature of this
connection is not characterized in detail and displays clear model-
speciﬁc differences. In osteodifferentiation we found that all three
MAP kinases display signs of activation. However, activation of JNK
was not related to either hydrogen peroxide or PARP1. Furthermore,
activation of Erk was only connected to PARylation but not to
hydrogen peroxide. Nevertheless, p38 activation, was dependent both
on hydrogen peroxide and on PARP1 and therefore in the rest of this
study we focused on the role of p38 in osteodifferentiation. Based on
previous studies reporting dephosphorylation of Erk by p38 [36] we
have also investigated whether increased activation of Erk under PARP
inhibition or PARP silencing is related to p38 but this mechanism
could not be conﬁrmed (data not shown). Using pharmacological
inhibitors of the three MAP kinase pathways we have investigated the
roles of p38, Erk1/2, and JNK in osteodifferentiation-coupled cell death.
Similar to hydrogen peroxide decomposition by catalase or PARP
inhibition/silencing, the inhibition of p38 but not that of the other
two MAP kinases affected cell death in our model. Participation of p38
in redox regulation of cell death pathways is consistent with some
other reports in the literature. For example Wei et al. [35] have shown
that exogenous hydrogen peroxide activates p38 that mediates
apoptosis of mesenchymal stem cells. Moreover, endogenous ROS
production has also been shown to activate p38 in photodynamic cell
death of cancer cell lines induced by a porphyrin derivative [44]. p38
signaling appears to converge on the mitochondria in our model as
indicated by the partial prevention of mitochondrial dysfunction and
glycolytic collapse in the presence of the p38 inhibitor. Similarly, Cai
et al. [32] have found that in a model of sodium arsenite-induced
apoptosis of PC12 cells, p38 phosphorylated the Bcl-2 family protein
BimEL and this proved to be essential for cell death. It seems plausible
to hypothesize that in our model of osteodifferentiation, p38 may be
activated by H2O2–PARP1 signaling and in turn, p38 may mediate
mitochondrial dysfunction and consequent apoptosis. How far down-
stream from PARP1 activation p38 may function in this regulatory
pathway was also investigated. We found that the interaction of these
two proteins is rather direct as the two proteins interact with each
other as veriﬁed by immunoprecipitation (Fig. 7). This interaction
requires p38 to translocate from the cytoplasm to the nucleus. This
translocation indeed takes place in differentiating cells and in the
nucleus the two proteins closely colocalize (Fig. 7). The nuclear
translocation of p38 has previously been reported in different stress
states [45,46] but not in any differentiation-related setting. The exact
nature of the connection between PARP1 activation and p38 as well as
the targets of p38 in the mitochondria and the nucleus requires
further investigation.
Our current data provide further support for the closely coupled
relationship between osteogenic differentiation and associated cell
death. It appears that most of the regulators identiﬁed in our
previous and current study affect both the differentiation pathway
and the associated cell death. Hydrogen peroxide, PARP1, and p38
mediate both osteodifferentiation and related cell death. Dexametha-
son, used as inducer of differentiation in our model, also triggers both
differentiation and apoptosis [47]. It appears plausible to hypothesize
that apoptosis of a substantial number of osteoprogenitors is
required for the efﬁcient completion of the differentiation program
and interventions affecting this death pathway will have the same
type of effect on the differentiation process. In support of this
hypothesis a recent report has shown that both necrotic and
apoptotic cells of osteoblast lineage serve as nuclei for calciﬁcation
on osteoblastic differentiation of mesenchymal stem cells [48].
In summary, we have established a new pathway promoting
cell death in differentiating osteoprogenitor cells. The pathway
involves production of hydrogen peroxide, DNA breakage, activa-
tion of PARP1, interaction between PARP1 and p38, and activation
of p38 MAP kinase converging on metabolic dysfunction and
culminating in cell death. These dead cells may serve as nuclei
for calciﬁcation and osteogenic differentiation explaining the
differentiation promoting effects of these events.
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